Identification of a Proteomic Signature to Predict Recurrence in Intermediate Risk Prostate Cancer

Shauna Malone; Suzanne Ackloo; J. Chen; Moyez Dharsee; Kambria H. Evans; Peter Kupchak; J. Li; Girish Sardana; Ping Zhu; Hongliang Zhao; Scott Grimes; Kyle Malone; L. Eapen; C. E; Robert M. MacRae; George Perry; Wayne S. Kendal; Rajiv Samant; Julia Craig; Christina Addison

doi:10.1016/j.ijrobp.2014.05.640

Related publications

Article2025

Abstract 3599: Proteomic risk factors for prostate cancer: A case-cohort study in EPIC

Zhe Huang, Mahboubeh Parsaeian, Vivian Viallon, Ziqiao Wang, Keren Papier, Trishna Desai, Stephanie Chan, Antonio Agudo, Carlotta Sacerdote, David C. Muller, Domenico Pali, Giovanna Masala, Nicholas J. Wareham, Raúl Zamora‐Ros, Roel Vermeulen, Rosario Tumino, Ian G. Mills, Nilanjan Chatterjee, Elizabeth A. Platz, Pietro Ferrari, Marc J. Gunter, Elio Riboli, Timothy J. Key, Joshua Atkins, Karl Smith-Byrne, Ruth C. Travis

Article2013

Combined low-FOXP3+ and -CD3+tumor infiltrating lymphocytes: a signature of stage II MSS colorectal cancer at high-risk of recurrence

Giuseppe Di, Giuseppe Celesti, Fabio Grizzi, Paolo Bianchi, Gianluca Basso, Federica Marchesi, Alberto Mantovani, Alberto Malesci, Luigi Laghi

Article2022

Identification of a Proteomic Signature to Predict Recurrence in Intermediate Risk Prostate Cancer

Discussion(0)

Related publications

Abstract 3599: Proteomic risk factors for prostate cancer: A case-cohort study in EPIC

Combined low-FOXP3+ and -CD3+tumor infiltrating lymphocytes: a signature of stage II MSS colorectal cancer at high-risk of recurrence

Adherence to a cholesterol-lowering diet and the risk of prostate cancer

Flavonoids and Prostate Cancer Risk: A Study in Italy

Nutrients and Risk of Prostate Cancer